Showing 4761-4770 of 5771 results for "".
- Ocular Therapeutix Provides Business Update and Response to COVID-19 Global Pandemichttps://modernod.com/news/ocular-therapeutix-provides-business-update-and-response-to-covid-19-global-pandemic/2477571/Ocular Therapeutix announced its response to the COVID-19 pandemic and related impact on Ocular Therapeutix’s business operations. “In the midst of the global COVID-19 pandemic, our first priority is for the safety and well-being of our employees, patients, clinical collaborators and custo
- Optometry’s Meeting Cancelled Due to COVID-19https://modernod.com/news/optometrys-meeting-cancelled-due-to-covid-19/2477565/Out of an abundance of caution amid the ongoing COVID-19 pandemic, the American Optometric Association (AOA) has officially cancelled the annual Optometry’s Meeting, scheduled to take place on June 24-28 in Washington DC. The annual meeting of both the AOA and American Optometric Student As
- Glaukos Provides Update on COVID-19 Impact and Preliminary Net Sales Range for First Quarterhttps://modernod.com/news/glaukos-provides-update-on-covid-19-impact-and-preliminary-net-sales-range-for-first-quarter/2477552/Glaukos provided an update on the impact of the COVID-19 pandemic on the company and announced a preliminary net sales range for its first quarter of 2020. Preliminary and Unaudited First Quarter 2020 Net Sales and COVID-19 Response Preliminary and unaudited net sales for the
- Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicianshttps://modernod.com/news/clearside-biomedical-establishes-scientific-advisory-board-with-distinguished-retinal-physicians/2477553/Clearside Biomedical announced the formation of a Scientific Advisory Board comprised of world-renowned retinal physicians to advise on the company’s research and development programs. “Over the past year, we have been building awareness around the potentia
- Novavax Accelerates Initiation of COVID-19 Vaccine Trial to Mid-Mayhttps://modernod.com/news/novavax-accelerates-initiation-of-covid-19-vaccine-trial-to-mid-may/2477554/Novavax announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology, and will initiate a first-in-human trial in mid-May. Novavax’ proprietary Matrix-M adjuvant will be incorporated w
- Nicox Outlines Plans to Progress NCX 4251 into Phase 2b Trial Following Positive Meeting with FDAhttps://modernod.com/news/nicox-outlines-plans-to-progress-ncx-4251-into-phase-2b-trial-following-positive-meeting-with-fda/2477548/Nicox SA announced that it has held a Type C meeting with the FDA in which the data from the recently completed Danube phase 2 clinical trial of NCX 4251 was reviewed and the next NCX 4251 trial designs were discussed. Given the positive Danube phase 2 trial results in reduction of the signs and
- Icare USA Completes Merger with CenterVuehttps://modernod.com/news/icare-usa-completes-merger-with-centervue/2477549/Icare USA announced that it has completed its merger with CenterVue after the acquisition of CenterVue by Revenio Group Corporation in April 2019. Financial terms of the deal were not disclosed. In March 2020, the two corporations were consolidated under a single management team. Co
- Roche Canada Launches Data Science Coalition to advance COVID-19 solutionshttps://modernod.com/news/roche-canada-launches-data-science-coalition-to-advance-covid-19-solutions/2477544/Roche Canada has announced the launch of the Ro
- TECLens Donates 10,000 PPE Face Shields to Workers on Front Linehttps://modernod.com/news/teclens-donates-10000-ppe-face-shields-to-workers-on-front-line/2477543/TECLens announced the donation of 10,000 PPE face shields to the Montefiore Hospital System in Bronx, New York, for distribution to its hospitals’ frontline care givers. “Several weeks ago we established a dedicated network of 3D print makers to make face shield componen
- Alcon Provides Update on COVID-19https://modernod.com/news/alcon-provides-update-on-covid-19/2477538/Alcon announced a series of updates stemming from the impact of COVID-19. Alcon has initiated business continuity plans designed to keep its associates and customers safe while continuing to deliver critical eye care needs for the global healthcare community. These plans include directing